Analytics: Approaches in quality assurance and quality control used in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Analytics
Analytical testing methods in pharma manufacturing. Chromatography, UHPLC, chiral. Near-infrared (NIR) and Raman spectroscopy. Anticounterfeiting. Dissolution testing. Cleaning validation. Extractables & leachables.

In the Spotlight

August 2, 2012
Pharmaceutical Technology

New product reviews for August 2012.

Analytical Tools for a Quality-by-Design Approach to Lyophilization

July 18, 2012

Equipment and Processing Report

Experts share insights into analytical tools and techniques.

A Lukewarm Reception

July 2, 2012

Pharmaceutical Technology

Careful attention to detail will help to prevent valuable assets from "melting" away.

Placket–Burman Designs

July 2, 2012

Pharmaceutical Technology

Applying current principals to traditional factorial designs.

35th Anniversary Special: Breakthroughs and Emerging Technologies in Manufacturing

July 2, 2012

Pharmaceutical Technology

Industry experts share their insight on solid-dosage and sterile manufacturing.

35th Anniversary Special: The Today and Tomorrow of Process Analytical Technology

July 2, 2012

Pharmaceutical Technology

Industry experts share perspectives on analytical instrumentation, methods, and data analysis.

How to Assess Preclinical Dose Formulation Homogeneity

July 2, 2012

Pharmaceutical Technology

Uniform dose formulation is key to meeting safety study requirements.

Atypical Visible Particles

July 2, 2012

Pharmaceutical Technology

An industry roundtable on how users and makers can best assess and manage black specks.

A Practical Guide to Pan Coating and Scale-Up

June 20, 2012

Equipment and Processing Report

An understanding of the pan-coating process based on first principles can support successful scale up.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here